News
-
Decision 2C_422/2022 of 16 January 2024
-
Decision 9C_726/2023 of 16 July 2024
-
Decision 4A_336/2023 of 12 July 2024
-
FOPH: Federal Council adopts measures to enhance supply on medicinal products
-
FOPH: Federal Council extends National Strategy for Non-Communicable Disease Prevention and National Addiction Strategy until 2028
-
FOPH: Ensuring the supply of in-vitro diagnostics and greater transparency for medical devices
-
FOPH: Federal Council adopted new ordinance on the activity of insurance intermediaries
-
Swissmedic: Update on information sheet for non-standardized medicinal products
-
Swissmedic Journal 07/2024
-
Swissmedic: Launch of first module of "swissdamed" – Swiss database on medical devices
-
Decision 2C_265/2023 of 9 July 2024
-
Swissmedic: Sarco suicide capsule does not qualify as a therapeutic product
-
Swissmedic approves first dengue fever vaccine for Swiss market
-
EMA supports pilot for joint medicine evaluation in Africa to establish African Medicines Agency
-
EMA launches pilot programme for expert advice on orphan medical devices in the EU
-
Decision 9C_664/2023 of 24 June 2024
-
Decision 9C_33/2024 of 24 June 2024
-
Decisions C-1301/2024 and C-1303/2024 of 16 July 2024
-
Public Consultation for ICH Guideline M14 launched in Switzerland
-
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 July 2024
-
Decision C-2510/2021, C-2513/2021 of 12 June 2024